165 related articles for article (PubMed ID: 15689157)
1. Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin.
Lu H; Chang DJ; Baratte B; Meijer L; Schulze-Gahmen U
J Med Chem; 2005 Feb; 48(3):737-43. PubMed ID: 15689157
[TBL] [Abstract][Full Text] [Related]
2. Molecular dynamic behavior and binding affinity of flavonoid analogues to the cyclin dependent kinase 6/cyclin D complex.
Khuntawee W; Rungrotmongkol T; Hannongbua S
J Chem Inf Model; 2012 Jan; 52(1):76-83. PubMed ID: 22172011
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for CDK6 activation by a virus-encoded cyclin.
Schulze-Gahmen U; Kim SH
Nat Struct Biol; 2002 Mar; 9(3):177-81. PubMed ID: 11828325
[TBL] [Abstract][Full Text] [Related]
4. Loop flexibility and solvent dynamics as determinants for the selective inhibition of cyclin-dependent kinase 4: comparative molecular dynamics simulation studies of CDK2 and CDK4.
Park H; Yeom MS; Lee S
Chembiochem; 2004 Dec; 5(12):1662-72. PubMed ID: 15505811
[TBL] [Abstract][Full Text] [Related]
5. Toward understanding the structural basis of cyclin-dependent kinase 6 specific inhibition.
Lu H; Schulze-Gahmen U
J Med Chem; 2006 Jun; 49(13):3826-31. PubMed ID: 16789739
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.
Russo AA; Jeffrey PD; Patten AK; Massagué J; Pavletich NP
Nature; 1996 Jul; 382(6589):325-31. PubMed ID: 8684460
[TBL] [Abstract][Full Text] [Related]
7. Formation of p27-CDK complexes during the human mitotic cell cycle.
Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division.
Lacy ER; Wang Y; Post J; Nourse A; Webb W; Mapelli M; Musacchio A; Siuzdak G; Kriwacki RW
J Mol Biol; 2005 Jun; 349(4):764-73. PubMed ID: 15890360
[TBL] [Abstract][Full Text] [Related]
9. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a.
Russo AA; Tong L; Lee JO; Jeffrey PD; Pavletich NP
Nature; 1998 Sep; 395(6699):237-43. PubMed ID: 9751050
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d.
Brotherton DH; Dhanaraj V; Wick S; Brizuela L; Domaille PJ; Volyanik E; Xu X; Parisini E; Smith BO; Archer SJ; Serrano M; Brenner SL; Blundell TL; Laue ED
Nature; 1998 Sep; 395(6699):244-50. PubMed ID: 9751051
[TBL] [Abstract][Full Text] [Related]
12. Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells.
Van Dross R; Yao S; Asad S; Westlake G; Mays DJ; Barquero L; Duell S; Pietenpol JA; Browning PJ
J Natl Cancer Inst; 2005 May; 97(9):656-66. PubMed ID: 15870436
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase.
De Azevedo WF; Mueller-Dieckmann HJ; Schulze-Gahmen U; Worland PJ; Sausville E; Kim SH
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2735-40. PubMed ID: 8610110
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of CDK5/p25 binding by CDK inhibitors.
Mapelli M; Massimiliano L; Crovace C; Seeliger MA; Tsai LH; Meijer L; Musacchio A
J Med Chem; 2005 Feb; 48(3):671-9. PubMed ID: 15689152
[TBL] [Abstract][Full Text] [Related]
15. Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects.
Mettey Y; Gompel M; Thomas V; Garnier M; Leost M; Ceballos-Picot I; Noble M; Endicott J; Vierfond JM; Meijer L
J Med Chem; 2003 Jan; 46(2):222-36. PubMed ID: 12519061
[TBL] [Abstract][Full Text] [Related]
16. Structural analysis of the inhibition of Cdk4 and Cdk6 by p16(INK4a) through molecular dynamics simulations.
Villacañas O; Pérez JJ; Rubio-Martínez J
J Biomol Struct Dyn; 2002 Dec; 20(3):347-58. PubMed ID: 12437373
[TBL] [Abstract][Full Text] [Related]
17. A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator.
Chou KC; Watenpaugh KD; Heinrikson RL
Biochem Biophys Res Commun; 1999 Jun; 259(2):420-8. PubMed ID: 10362524
[TBL] [Abstract][Full Text] [Related]
18. Two different bindings of p21 Cdk inhibitor to cyclin/Cdk complex.
Nakanishi M; Kagawa Y; Takahashi H; Matsushime H
Leukemia; 1997 Apr; 11 Suppl 3():356-7. PubMed ID: 9209388
[TBL] [Abstract][Full Text] [Related]
19. Structural insights of cyclin dependent kinases: Implications in design of selective inhibitors.
Kalra S; Joshi G; Munshi A; Kumar R
Eur J Med Chem; 2017 Dec; 142():424-458. PubMed ID: 28911822
[TBL] [Abstract][Full Text] [Related]
20. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
